Summary
Amgen Inc. announced a significant addition to its Board of Directors with the appointment of S. Omar Ishrak, effective immediately as of July 29, 2021. Dr. Ishrak brings extensive experience in the healthcare and technology sectors, having previously held leadership positions such as Executive Chairman and CEO of Medtronic plc, and CEO of GE Healthcare Systems. His appointment is expected to enhance the Board's strategic capabilities and oversight. Dr. Ishrak will serve on the Corporate Responsibility and Compliance Committee and the Compensation and Management Development Committee. His appointment increases the Board's total director count to 12, with 11 of those directors being independent, reinforcing the company's commitment to strong corporate governance. Dr. Ishrak will receive standard director compensation, including a pro-rated retainer and restricted stock units, aligning his interests with those of the company's shareholders.
Key Highlights
- 1Amgen appointed S. Omar Ishrak to its Board of Directors, effective July 29, 2021.
- 2Dr. Ishrak possesses extensive leadership experience in the medical technology and healthcare sectors, including CEO roles at Medtronic and GE Healthcare.
- 3He will serve on the Corporate Responsibility and Compliance Committee and the Compensation and Management Development Committee.
- 4The Board will now consist of 12 directors, 11 of whom are independent, strengthening corporate governance.
- 5Dr. Ishrak will receive standard director compensation, including a pro-rated annual retainer and restricted stock units.
- 6There are no disclosed related-party transactions or arrangements concerning Dr. Ishrak's appointment.
- 7A press release announcing the appointment is attached as Exhibit 99.1.